Treatment with HNG reduced IL-13 protein levels by 57.63 % in AMD cells: P = 0.0421; AMD UN CL = 1 ± 0.1448 a.u.; AMD HNG CL = 0.4237 ± 0.1280 a.u. (Figure 4G). This evidence concerns the gene IL13 and age-related macular degeneration.